• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Akanda Corp.

    5/1/25 5:00:02 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AKAN alert in real time by email
    6-K 1 ea024027601-6k_akanda.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION 

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

     

    Commission File Number: 001-41324

     

    AKANDA CORP.

    (Name of registrant)

     

    100 King Street W, Suite 1600

    Toronto, Ontario M5X 1G5, Canada 

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

      x Form 20-F ¨ Form 40-F  

     

     

     

     

     

    EXPLANATORY NOTE

     

    Akanda Corp. (the “Company”) held its Annual General and Special Meeting of Shareholders for the fiscal year 2024 (the “Meeting”) on April 30, 2025. There were 2,275,904 common shares to be voted, of which 312,049 were voted in person or by proxy. The following matters were submitted to a vote of the Company’s shareholders at the Meeting.

     

    Proposal 1. A proposal to fix the number of directors for the Corporation at five. The results of the voting were as follows:

     

    For   Against
    308,629   3,420

     

    Proposal 2. A proposal to elect five directors to serve until the next meeting of shareholders at which the election of directors is considered, or until his or her successor is duly elected or appointed, unless he or she resigns, is removed or becomes disqualified in accordance with the articles of the Company or the Business Corporations Act. The nominees, Christopher Cooper, David Jenkins, Jatinder Dhaliwal, Katharyn Field, and Usama Chaudhry, were elected to serve as directors. The results of the voting were as follows:

     

    Nominees   Votes For   Withheld
    Christopher Cooper   308,252   3,795
    David Jenkins   308,364   3,684
    Jatinder Dhaliwal   308,982   3,066
    Katharyn Field   306,118   5,930
    Usama Chaudhry   308,212   3,836

     

    Proposal 3. A proposal to re-appoint GreenGrowth CPAs, as auditors of the Company for the 2025 fiscal year, and to authorize the audit committee of the Company to fix the auditors' remuneration and the terms of their engagement. The proposal was approved and results of the voting were as follows:

     

    For   Withheld
    309,435   2,613

     

    Proposal 4. A proposal to consider and, if deemed appropriate, to pass, a special resolution, approving one or more amendments to the articles of the Company for one or more future consolidations of the Company’s issued and outstanding common shares on the basis of consolidation ratios to be selected by the Board of Directors of the Company within a range between two pre-consolidation common shares for one post-consolidation common share and 100 pre-consolidation common shares for one post-consolidation common share, provided that, (A) the cumulative effect of the share consolidation shall not result in a consolidation ratio that exceeds 100 pre-share consolidation common shares for one post-share consolidation common share, and (B) such share consolidation occurs prior to the earlier of the 12 month anniversary of the meeting and the next annual meeting of shareholders; and file the articles of amendment to give effect to the share consolidation at the selected consolidation ratio(s). The proposal was approved and results of the voting were as follows:

    For   Against
    302,566   9,482

     

    As a result of the approval of Proposal 4, the Company's Board of Directors, if it deems it appropriate to approve such a consolidation, will determine the share consolidation ratio and thereafter provide public notice of the share consolidation on a Report on Form 6-K.

     

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      AKANDA CORP.
      (Registrant)
       
         
    Date: May 1, 2025 By: /s/ Katie Field
        Name: Katie Field
        Title: Interim Chief Executive Officer and Director

     

     

     

     

     

    Get the next $AKAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AKAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AKAN
    Financials

    Live finance-specific insights

    See more
    • Halo Collective Completes Acquisition of Premium Indoor Grow and Distribution Hub in Portland, Oregon

      TORONTO, Sept. 22, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced, further to its press release dated August 27, 2021, that it has completed the acquisition of all of the substantial assets of three operating entities doing business as Pistil Point in Oregon which collectively hold multiple cannabis licenses. With this transaction, Halo now has full ownership of a range of indoor and outdoor cultivation, manufacturing, and distributions assets, along with an expanded library of genetics that is expected to allow the Company to continue to execute its vertically integrated strategy in Oregon with enhanced compet

      9/22/22 5:00:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Halo Collective Announces Westwood Dispensary Completion, Local Inspections Passed, and Planned Opening for Second Budega™ in California

      TORONTO, April 12, 2022 /PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced that its Budega Westwood Dispensary passed its Los Angeles inspection and is expected to open within 30 days. The Budega Westwood location is perfectly located nestled in between Westwood to the west and Beverly Hills to the east, right off of one of LA's most traveled and famous thoroughfares for locals and visitors, the Santa Monica Boulevard (10461 Santa Monica Blvd) and within two miles of the University of Los Angeles California campus. The facility is leased and near complete with renovations of its approximately 1,500 square foot prime retail

      4/12/22 4:40:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Univest Securities, LLC Announces Closing of $5 Million Underwritten Public Offering for its Client Akanda Corp. (NASDAQ: AKAN)

      New York, March 27, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of underwritten public offering (the "Offering") of 3,087,443 common stock priced at $0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares with respect to the underwritten public offering for its client Akanda Corp. (NASDAQ:AKAN) ("Akanda" or the "Company"), an international medical cannabis company. Under the terms of the securities purchase agreement, the Company has agreed to sell to the institutional investors a total of 3,087,443 sh

      3/27/24 4:45:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility

      International medical cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN, WKN: A3DG83))) announces that Akanda (the "Optionee" the "Company") and 1107385 B.C. LTD (the "Owner") have agreed upon terms to purchase farming land and related operations and licenses. The key deal terms are as follows: Akanda will issue a non-refundable payment equal to One Million Eight Hundred Thousand United States Dollars (USD1,800,000) and if paid in common shares of Akanda will be based on formula to calculate the per share price as set forth in the agreement. The initial payment will be broken up into the First Option Payment, the Second Option Payment and the Third Option Payment, u

      9/20/23 9:00:00 AM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

      International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN) today announced that the Company has received a written notification (the "Notification Letter") on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that the closing bid price of the Company's common shares, no par value ("Common Shares"), was below $1.00 per share for a period of 30 consecutive business days. The Notification Letter does not impact the Company's listing on the

      7/6/23 4:18:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Akanda Corp. (Amendment)

      SC 13D/A - AKANDA CORP. (0001888014) (Subject)

      2/20/24 6:01:03 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Akanda Corp.

      SC 13D - AKANDA CORP. (0001888014) (Subject)

      2/20/24 5:17:13 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Akanda Corp. (Amendment)

      SC 13G/A - AKANDA CORP. (0001888014) (Subject)

      2/20/24 12:55:32 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    SEC Filings

    See more
    • SEC Form 6-K filed by Akanda Corp.

      6-K - AKANDA CORP. (0001888014) (Filer)

      5/1/25 5:00:02 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 20-F filed by Akanda Corp.

      20-F - AKANDA CORP. (0001888014) (Filer)

      4/30/25 3:00:22 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by Akanda Corp.

      6-K - AKANDA CORP. (0001888014) (Filer)

      4/18/25 1:46:03 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care

    $AKAN
    Leadership Updates

    Live Leadership Updates

    See more
    • Halo Collective Announces Change of Auditors and Failure to File Cease Trade Order

      Toronto, Ontario--(Newsfile Corp. - June 22, 2023) - Halo Collective Inc. (NEO: HALO) (OTCQB:HCANF) (FSE: A9K0) ("Halo" or the "Company") announces today that it has changed its auditor (the "Change of Auditor") from Macias Gini & O'Connell LLP (the "Former Auditor") to GreenGrowth CPAs (the "Successor Auditor"). The Former Auditor resigned effective June 19, 2023, and the Company's board of directors, upon the audit committee's recommendation, appointed the Successor Auditor to fill the resulting vacancy until the close of the next annual meeting of the Company's shareholders.There was no modified opinion, or other opinion, issued by the Former Auditor in connection with its audit of the Co

      6/22/23 1:06:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director

      International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ:AKAN) today announced its subsidiary Canmart Ltd. brought Tejinder Virk's Service Agreement dated June 2, 2021 (the "Service Agreement") to an immediate end with effect from February 13th, 2023. As disclosed on February 7th, 2023, the Company disclosed Mr. Virk's attempt to end the Service Agreement without providing the requisite period of notice required under the Service Agreement, his interpretation of the Service Agreement, and allegations of Breach of Contract. On February 13th, 2023, the Company informed Mr. Virk that it had reached the conclusion that it has a right to bring the Service

      2/16/23 5:05:00 PM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care
    • /R E P E A T -- Halo Collective Appoints Katie Field as Chairman of the Board/

      TORONTO, Aug. 12, 2022 /PRNewswire/ -  Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) today announced the appointment of Katie Field, Chief Executive Officer of Halo, to Chairman of the board of directors of the Company (the "Board"), effective immediately. Current Chairman Ryan Kunkel has resigned from the Board to focus on other professional endeavors. To the knowledge of the Company, Ms. Field is the second woman to serve as Chairman and CEO of a publicly traded cannabis company, the first being Kim Rivers of Trulieve (CSE:TRUL). Ca

      8/12/22 8:00:00 AM ET
      $AKAN
      Medicinal Chemicals and Botanical Products
      Health Care